AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Metoclopramide Hydrochloride in Nigeria
5 products registered with NAFDAC — 4 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Mederax Tablets Tablet | 04-6476 | Vixa Pharmaceutical Company Limited | active | 25 Aug 2026 |
| Festmetor Tablets Tablet | B4-0889 | Manfes Pharmaceutical Company Limited | active | 25 Aug 2026 |
| Metaclim Injection Solution for injection | A4-6082 | Climax Pharmaceutical Chemist Limited | active | 23 Jun 2026 |
| Metoclop-10 Tablet Tablet | 04-5946 | De - Godstime Industry Nig Ltd | active | 28 Mar 2026 |
| ECNU METOCLOPRA MIDE INJECTION/1 X 10 AMPOULES | B4-7225 | ECNU PHARM CO. LTD 31 | expired | 7 Aug 2022 |
Metoclopramide Hydrochloride — NAFDAC Registration Details
NAFDAC (Nigeria) has 5 registered products containing Metoclopramide Hydrochloride, of which 4 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Metoclopramide Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.